While most ovarian cancers are bilateral, ICD 10 terminology has not previously included a bilateral ovarian cancer code. This was appealed by the SGO Coding and Reimbursement Subcommittee. Each year, the Centers for Medicare & Medicaid Services (CMS) releases documents outlining new, deleted, and revised ICD-10 codes to become effective the new fiscal year starting each October. The FY22 updates effective Oct. 1, 2021 include 159 additions, 25 deletions, 27 revisions, and several general coding guideline updates. Show There are two new diagnosis codes specific to bilateral ovaries for both primary and secondary malignancy. SGO coding committee requested these additions back in 2019 and we have been heard!
The laterality of an ovarian cancer is best assigned by the Gynecologic Oncologist. These codes assign the site of the primary, not the sites of metastatic disease. Most often ovarian cancers are advanced and bilateral. The new code allows that to be recorded. The unspecified code should rarely be used: if there is enough data to make the diagnosis of an ovarian cancer then the side(s) will generally be apparent as well.
These are the codes used when there is metastatic disease in one or both ovaries. The appropriate code for the site of the primary cancer (e.g. breast, colon) may also be added. To see details on all ICD-10-CM changes effective Oct. 1, 2021, visit the CMS website. Bridget Toomey, MS, CPC, CPB, CPPM, CPCO, AAPC Fellow, is the assistant director of clinical operations in the department of Obstetrics and Gynecology at the University of Iowa Health Care. Ovarian cancer, considered as the tenth most common cancer among women in the United States, refers to any cancerous growth that appears in the ovary (reproductive glands). It occurs when abnormal cells in the ovary begin to multiply out of control and form a tumor. Most ovarian cancers develop initially in the epithelium, or outer lining of the ovary and often come with symptoms such as – abdominal bloating and pain, weight loss, abnormal fullness after eating, frequent urination, difficulty eating, discomfort in the pelvis area and changes in bowel habits, such as constipation. If left untreated, this tumor can spread to other parts of the body. With appropriate and timely treatment, the serious complications caused by ovarian cancer can be reversed. It is important for physicians to instruct their medical coding outsourcing service providers or clinical staff to be specific and document their diagnosis and medical procedures with accurate medical codes. Reports suggest that about 22,000 women in the US will receive a diagnosis of ovarian cancer yearly and around 14,000 are expected to die from this disease (2017 statistics). The exact cause of ovarian cancer is not clear; however physicians have identified certain factors that can increase the risk of the disease which include – age, family history, reproductive history, the use of certain fertility drugs or hormone therapies, endometriosis and obesity. Diagnosis and Treatment Ovarian cancer can be hard to detect in the early stages as most signs and symptoms do not appear until the disease has progressed fully. Early and timely diagnosis helps in better treatment. It is estimated that early diagnosis of ovarian cancer (in the primary stages) leads to 94 percent chance of survival for at least 5 years. A woman’s lifetime risk for developing ovarian cancer is 1 in 75. There is no specific routine diagnostic screening test available for detecting ovarian cancer. However, physicians may recommend a series of imaging tests/procedures such as transvaginal ultrasound (TVUS), abdominal and pelvic CT scan, blood tests, laparoscopy, MRI scan, colonoscopy and abdominal fluid aspiration in order to determine the size, shape and structure of your ovaries. In addition, biopsy will be performed to remove the tumor or part of the tumor to examine for the presence of cancer cells. The type of treatment for this cancer may depend on how far the cancer has spread. Treatment methods for this condition may include – chemotherapy, radiation, hormone therapy, targeted therapy and surgery to stage the cancer and remove the tumor. Radiology medical coding involves using the specific ICD-10 diagnosis codes, CPT procedure codes and HCPCS codes for reporting ovarian cancer on your medical claims. ICD-10 Codes to Indicate Diagnosis of Ovarian Cancer
CPT Codes The standard treatment procedure for ovarian cancer for women involves a debulking surgery (performed by a gynecologic oncologist) wherein the tumor is removed as much as possible. This is followed by a combination of platinum compound (usually cisplatin or carboplatin) and taxane such as paclitaxel (Taxol®) or docetaxel (Taxotere®) chemotherapy drugs given as an IV (put into a vein) on an every 3 to 4 week schedule. CPT Codes for Debulking Surgery
CPT Codes for Chemotherapy Administration
HCPCS Codes
For accurate and timely medical billing and claims submission, radiology practices providing treatment for ovarian cancer can outsource their medical tasks to an experienced medical billing company that offers the services of AAPC-certified coding specialists. The general outlook for ovarian cancer varies, depending on its stage and type. Generally, cancer in the ovaries is very rare among young women. As per estimates from the Ovarian Cancer Research Fund Alliance, the median age of a diagnosis is 63 years. The risk of developing this condition could be higher if you have a strong family history of ovarian cancer or if you carry certain genetic mutations. Therefore, it is important to report any unusual symptoms to your physician immediately. When the symptoms are persistent and do not resolve with normal interventions (such as physical exercise, diet changes, body rest, laxatives) it is imperative for a woman to visit her physician. In most cases, ovarian cancer symptoms are described as vague and silent and occur in advanced stages when tumor growth creates pressure on the bladder and rectum, and fluid begins to form. It is estimated that about 19 percent of ovarian cancer is diagnosed in its early stages. The sooner you identify the symptoms (in its early stages); the better will be its further treatment and your chances of survival. What is ICDFamily history of malignant neoplasm, unspecified
Z80. 9 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes. The 2023 edition of ICD-10-CM Z80. 9 became effective on October 1, 2022.
Is Z15 01 a primary diagnosis?Genetic susceptibility indicates that a person has a gene that increases the risk of that person developing the disease. Codes from category Z15 should not be used as principal or first-listed codes.
Can Z85 3 be used as a primary diagnosis code?Z85. 3 can be billed as a primary diagnosis if that is the reason for the visit, but follow up after completed treatment for cancer should coded as Z08 as the primary diagnosis.
What is diagnosis code Z80 3?ICD-10 code: Z80. 3 Family history of malignant neoplasm of breast.
|